| CRISPR Medicine | This is an overview of our news stories
Some of the best links we picked up around the internet
YolTech Therapeutics announced on Monday that the Chinese National Medical Products Administration has approved its IND application for YOLT-101 in...
CRISPR cytosine base editors have been refined through directed evolution of enzyme recognition loops to enable highly precise DNA editing with...
A comprehensive CRISPR-CAS whole-genome screen has revealed key proteins controlling anti-sense oligonucleotide (ASO) activity, with a particular...
A tamoxifen-inducible CRISPRa/i system has been developed to enable reversible and rapid control of gene expression in mammalian cells. The platform...